Natera
NTRA
$91.66
Share price
0.42%
Change (1 day)
80.72%
Change (1 year)
Categories
Natera (NTRA) - Cash on Hand
Cash on Hand as of December 2023 : $0.87 B
According to Natera's latest financial reports the company has $0.87 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Natera - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.87 B | -2.16% |
| 2022-12-31 | $0.89 B | -1.74% |
| 2021-12-31 | $0.91 B | 24.01% |
| 2020-12-31 | $0.73 B | 67.19% |
| 2019-12-31 | $0.44 B | 186.6% |
| 2018-12-31 | $0.15 B | 29.45% |
| 2017-12-31 | $0.11 B | -18.65% |
| 2016-12-31 | $0.14 B | -36.62% |
| 2015-12-31 | $0.23 B | 164.45% |
| 2014-12-31 | $87.17 M | 185.86% |
| 2013-12-31 | $30.49 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Vertex Pharmaceuticals VRTX | $11.21 B | 1,176.29% | 🇺🇸 USA |
 Prothena PRTA | $0.61 B | -29.60% | 🇮🇪 Ireland |
 Paratek Pharmaceuticals
PRTK | $42.68 M | -95.14% | 🇺🇸 USA |